Delivery Order SPE2DB20D3304-SPE2DB25FW8A9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $1,187.00. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract with performance executed from the contractor's Conshohocken, Pennsylvania location. The award is a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $11,427.01. This firm fixed-price delivery order, with an ultimate completion date of June 9, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 8, 2025, for Clonidine HCl ER 0.17 mg tablets (30-count supply) with a ceiling value of $1,491.84. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 9, 2025, and involves no set-aside designation. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets in a quantity of 60 count, with a ceiling value of $1,012.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded through open competition without a set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clonidine HCl ER 0.1 mg tablets (60-count) on August 27, 2025, with a ceiling value of $4,493.28 and an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,159.04 to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes a firm fixed-price contract structure with no set-aside designation. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Clonidine HCl ER 0.17 mg tablets. The contract has a ceiling value of $4,590.39 and a completion date of June 21, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,528.37 delivery order contract is for the supply of Clonidine HCL ER 0.1 mg tablets to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of January 27, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.17 MG Tablets in 30-count packages, with a ceiling value of $1,081.95 and a period of performance through April 16, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,810.82 firm fixed price delivery order is for the supply of 4564147411 - Clonidine HCL ER 0.1 mg Tablets, 60s. This award is a child order under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8A9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clonidine HCL ER 0.1 mg tablets (60-count) with a ceiling value of $2,304.37. The award was issued on July 17, 2025, with an ultimate completion date of July 18, 2025, and utilized firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for federal procurement through its extensive portfolio of pharmaceuticals and medical commodities. The company's federal contract awards with DLA demonstrate its capability to supply diverse therapeutic products ranging from specialty medications to vaccines and medical devices across multiple healthcare domains. This particular delivery order for clonidine, a cardiovascular and pain management medication, exemplifies the routine pharmaceutical procurement executed under the broader IDC framework to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/17/25 |